TOT BIOPHARM International Company Limited (1875.HK)

HKD 2.04

(-0.49%)

Revenue Summary of TOT BIOPHARM International Company Limited

TOT BIOPHARM International Company Limited's latest annual revenue in 2023 was 780.62 Million CNY , up 76.54% from previous year.
TOT BIOPHARM International Company Limited's latest quarterly revenue in 2024 Q2 was 520.6 Million CNY , down 0.0% from previous quarter.
TOT BIOPHARM International Company Limited reported a annual revenue of 442.17 Million CNY in annual revenue 2022, up 479.34% from previous year.
TOT BIOPHARM International Company Limited reported a annual revenue of 76.32 Million CNY in annual revenue 2021, up 239.36% from previous year.
TOT BIOPHARM International Company Limited reported a quarterly revenue of 780.62 Million CNY for 2023 FY, up 76.54% from previous quarter.
TOT BIOPHARM International Company Limited reported a quarterly revenue of 452.56 Million CNY for 2023 Q4, down 0.0% from previous quarter.

Annual Revenue Chart of TOT BIOPHARM International Company Limited (2023 - 2017)

Historical Annual Revenue of TOT BIOPHARM International Company Limited (2023 - 2017)

Year	Revenue	Revenue Growth
2023	780.62 Million CNY	76.54%
2022	442.17 Million CNY	479.34%
2021	76.32 Million CNY	239.36%
2020	22.49 Million CNY	-50.36%
2019	45.3 Million CNY	15.53%
2018	39.21 Million CNY	-24.01%
2017	51.6 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q2	520.6 Million CNY	0.0%
2023 FY	780.62 Million CNY	76.54%
2023 Q4	452.56 Million CNY	0.0%
2023 Q2	328.06 Million CNY	0.0%
2022 FY	442.17 Million CNY	479.34%
2022 Q4	260.15 Million CNY	0.0%
2022 Q2	182.01 Million CNY	0.0%
2021 Q2	23.13 Million CNY	0.0%
2021 Q4	53.19 Million CNY	0.0%
2021 FY	76.32 Million CNY	239.36%
2020 Q4	9.46 Million CNY	0.0%
2020 FY	22.49 Million CNY	-50.36%
2020 Q2	13.03 Million CNY	0.0%
2019 Q2	24.6 Million CNY	0.0%
2019 Q4	20.7 Million CNY	0.0%
2019 FY	45.3 Million CNY	15.53%
2018 Q2	9.8 Million CNY	0.0%
2018 FY	39.21 Million CNY	-24.01%
2018 Q1	9.8 Million CNY	0.0%
2018 Q4	11.32 Million CNY	0.0%
2017 Q2	12.9 Million CNY	0.0%
2017 Q4	9.8 Million CNY	0.0%
2017 Q1	12.9 Million CNY	0.0%
2017 FY	51.6 Million CNY	0.0%
2016 Q4	12.9 Million CNY	0.0%

Peer Revenue Comparison of TOT BIOPHARM International Company Limited

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	-61.048%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	85.334%